1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Li, D.
Lu, S.
Gu, X.
Liang, S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
279
37734
37740
10.1074/jbc.M405765200
15201273
Structure-Activity Relationships of Hainantoxin-IV and Structure Determination of Active and Inactive Sodium Channel Blockers.
2004
CN
Acta Biochim.Biophys.Sinica
0582-9879
34
516
519
Synthesis and Oxidative Refolding of Hainantoxin-Iv
2002
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
3999.629
HAINANTOXIN-IV
1
nat
polymer
HnTx-IV
no
yes
ECLGFGKGCNPSNDQCCKSSNLVCSRKHRWCKYEI(NH2)
ECLGFGKGCNPSNDQCCKSSNLVCSRKHRWCKYEIX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Ornithoctonus
sample
209901
Ornithoctonus hainana
VENOM
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
1
0
2003-01-14
1
1
2008-04-29
1
2
2011-07-13
1
3
2017-11-29
RCSB
Y
RCSB
2002-12-30
REL
REL
THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES.
structures with the lowest energy
50
20
NOESY
DQF-COSY
TOCSY
20
4.00
1
atm
288.00
K
THE STRUCTURES ARE BASED ON 566 NOE-DERIVED DISTANCE CONSTRAINTS, 14 DIHEDRAL ANGEL RESTRAINTS, 9 FAKE DISTANCE RESTRAINTS FROM DISULFIDE BONDS AND 8 HYDROGEN-BOND CONSTRAINTS.
simulated annealing
1
5.5 MM HAINANTOXIN-IV MMOL/L DEUTERIUM ACETIC ACID BU 90%H2O , 10%D2O
BRUNGER
refinement
X-PLOR
3.851
structure solution
FELIX
98.0
500
Bruker
DRX
GLU
1
n
1
GLU
1
A
CYS
2
n
2
CYS
2
A
LEU
3
n
3
LEU
3
A
GLY
4
n
4
GLY
4
A
PHE
5
n
5
PHE
5
A
GLY
6
n
6
GLY
6
A
LYS
7
n
7
LYS
7
A
GLY
8
n
8
GLY
8
A
CYS
9
n
9
CYS
9
A
ASN
10
n
10
ASN
10
A
PRO
11
n
11
PRO
11
A
SER
12
n
12
SER
12
A
ASN
13
n
13
ASN
13
A
ASP
14
n
14
ASP
14
A
GLN
15
n
15
GLN
15
A
CYS
16
n
16
CYS
16
A
CYS
17
n
17
CYS
17
A
LYS
18
n
18
LYS
18
A
SER
19
n
19
SER
19
A
SER
20
n
20
SER
20
A
ASN
21
n
21
ASN
21
A
LEU
22
n
22
LEU
22
A
VAL
23
n
23
VAL
23
A
CYS
24
n
24
CYS
24
A
SER
25
n
25
SER
25
A
ARG
26
n
26
ARG
26
A
LYS
27
n
27
LYS
27
A
HIS
28
n
28
HIS
28
A
ARG
29
n
29
ARG
29
A
TRP
30
n
30
TRP
30
A
CYS
31
n
31
CYS
31
A
LYS
32
n
32
LYS
32
A
TYR
33
n
33
TYR
33
A
GLU
34
n
34
GLU
34
A
ILE
35
n
35
ILE
35
A
NH2
36
n
36
NH2
36
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
LYS
7
A
O
LYS
7
A
N
CYS
31
A
N
CYS
31
A
N
LYS
32
A
N
LYS
32
A
O
VAL
23
A
O
VAL
23
1
A
ARG
26
0.314
SIDE CHAIN
1
A
ARG
29
0.318
SIDE CHAIN
2
A
ARG
26
0.313
SIDE CHAIN
2
A
ARG
29
0.305
SIDE CHAIN
3
A
ARG
26
0.303
SIDE CHAIN
3
A
ARG
29
0.316
SIDE CHAIN
4
A
ARG
26
0.318
SIDE CHAIN
4
A
ARG
29
0.318
SIDE CHAIN
5
A
ARG
26
0.318
SIDE CHAIN
5
A
ARG
29
0.317
SIDE CHAIN
6
A
ARG
26
0.310
SIDE CHAIN
6
A
ARG
29
0.310
SIDE CHAIN
7
A
ARG
26
0.312
SIDE CHAIN
7
A
ARG
29
0.317
SIDE CHAIN
8
A
ARG
26
0.313
SIDE CHAIN
8
A
ARG
29
0.293
SIDE CHAIN
9
A
ARG
26
0.317
SIDE CHAIN
9
A
ARG
29
0.311
SIDE CHAIN
10
A
ARG
26
0.316
SIDE CHAIN
10
A
ARG
29
0.314
SIDE CHAIN
11
A
ARG
26
0.318
SIDE CHAIN
11
A
ARG
29
0.313
SIDE CHAIN
12
A
ARG
26
0.283
SIDE CHAIN
12
A
ARG
29
0.317
SIDE CHAIN
13
A
ARG
26
0.316
SIDE CHAIN
13
A
ARG
29
0.313
SIDE CHAIN
14
A
ARG
26
0.317
SIDE CHAIN
14
A
ARG
29
0.314
SIDE CHAIN
15
A
ARG
26
0.306
SIDE CHAIN
15
A
ARG
29
0.300
SIDE CHAIN
16
A
ARG
26
0.310
SIDE CHAIN
16
A
ARG
29
0.316
SIDE CHAIN
17
A
ARG
26
0.312
SIDE CHAIN
17
A
ARG
29
0.309
SIDE CHAIN
18
A
ARG
26
0.316
SIDE CHAIN
18
A
ARG
29
0.314
SIDE CHAIN
19
A
ARG
26
0.317
SIDE CHAIN
19
A
ARG
29
0.311
SIDE CHAIN
20
A
ARG
26
0.295
SIDE CHAIN
20
A
ARG
29
0.305
SIDE CHAIN
1
A
CYS
2
-161.05
91.92
1
A
ASP
14
62.87
99.04
3
A
ASP
14
53.38
74.76
3
A
ASN
21
52.40
72.85
6
A
CYS
2
61.45
96.46
6
A
ASP
14
58.03
80.96
7
A
ASP
14
56.43
85.47
8
A
CYS
2
60.61
92.30
8
A
ASN
13
-116.42
71.97
9
A
ASP
14
55.33
87.64
10
A
ASP
14
58.18
89.44
12
A
ASP
14
58.52
81.71
13
A
ASP
14
59.35
87.44
14
A
ASP
14
54.07
74.91
15
A
CYS
2
58.37
84.11
15
A
ASP
14
57.33
80.31
16
A
ASP
14
62.29
93.58
17
A
ASP
14
53.18
80.15
18
A
ASN
13
-110.98
69.34
19
A
ASP
14
57.24
84.18
20
A
ASP
14
55.64
82.73
HAINANTOXIN-IV
THREE DIMENSIONAL SOLUTION STRUCTURE OF HAINANTOXIN-IV BY 2D 1H-NMR
1
N
N
disulf
2.019
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
17
A
SG
CYS
17
1_555
disulf
2.020
A
CYS
9
A
SG
CYS
9
1_555
A
CYS
24
A
SG
CYS
24
1_555
disulf
2.021
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
31
A
SG
CYS
31
1_555
covale
1.312
A
ILE
35
A
C
ILE
35
1_555
A
NH2
36
A
N
NH2
36
1_555
TOXIN
NEUROTOXIN, INHIBITOR CYSTINE KNOT MOTIF, TOXIN
TXHA4_SELHA
UNP
1
1
P83471
ECLGFGKGCNPSNDQCCKSSNLVCSRKHRWCKYEI
1
35
1NIY
1
35
P83471
A
1
1
35
3
anti-parallel
parallel
A
LYS
7
A
LYS
7
A
CYS
9
A
CYS
9
A
TRP
30
A
TRP
30
A
TYR
33
A
TYR
33
A
LEU
22
A
LEU
22
A
SER
25
A
SER
25
BINDING SITE FOR RESIDUE NH2 A 36
Software
2
A
GLU
34
A
GLU
34
2
1_555
A
ILE
35
A
ILE
35
2
1_555
1
P 1